Slingshot members are tracking this event:
Initiation of the Iomab-B's pivotal Phase 3 trial in AML refractory/relapsing patients
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jun 10, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Iomab-b